Literature DB >> 17043046

Patient perception of UK scleroderma services--results of an anonymous questionnaire.

A H Mawdsley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17043046     DOI： 10.1093/rheumatology/kel337

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 2.  Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.

Authors:  Genevieve Gyger; Murray Baron
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 3.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

4.  Downregulation of Vascular Hemeoxygenase-1 Leads to Vasculopathy in Systemic Sclerosis.

Authors:  Rebecca L Ross; Georgia Mavria; Francesco Del Galdo; Jacobo Elies
Journal:  Front Physiol       Date:  2022-05-05       Impact factor: 4.755

5.  Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.

Authors:  Zsuzsanna H McMahan; Fredrick M Wigley
Journal:  Int J Clin Rheumtol       Date:  2010

6.  A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost.

Authors:  Paola Caramaschi; Nicola Martinelli; Alessandro Volpe; Sara Pieropan; Ilaria Tinazzi; Giuseppe Patuzzo; Helal Mahamid; Lisa Maria Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2009-03-20       Impact factor: 2.980

7.  Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Authors:  Marco Matucci-Cerinic; Christopher P Denton; Daniel E Furst; Maureen D Mayes; Vivien M Hsu; Patrick Carpentier; Fredrick M Wigley; Carol M Black; Barri J Fessler; Peter A Merkel; Janet E Pope; Nadera J Sweiss; Mittie K Doyle; Bernhard Hellmich; Thomas A Medsger; Adele Morganti; Fabrice Kramer; Joseph H Korn; James R Seibold
Journal:  Ann Rheum Dis       Date:  2010-08-30       Impact factor: 19.103

8.  Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis.

Authors:  Anne A Schouffoer; Elisabeth J M Zirkzee; Stella M Henquet; Monique A A Caljouw; Gerda M Steup-Beekman; Jacob M van Laar; Theodora P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2011-01-18       Impact factor: 2.980

9.  The educational needs of people with systemic sclerosis: a cross-sectional study using the Dutch version of the Educational Needs Assessment Tool (D-ENAT).

Authors:  Anne Schouffoer; Mwidimi E Ndosi; Thea P M Vliet Vlieland; Jorit J L Meesters
Journal:  Rheumatol Int       Date:  2015-08-31       Impact factor: 2.631

10.  A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.

Authors:  Jack D Wilkinson; Sarah A Leggett; Elizabeth J Marjanovic; Tonia L Moore; John Allen; Marina E Anderson; Jason Britton; Maya H Buch; Francesco Del Galdo; Christopher P Denton; Graham Dinsdale; Bridgett Griffiths; Frances Hall; Kevin Howell; Audrey MacDonald; Neil J McHugh; Joanne B Manning; John D Pauling; Christopher Roberts; Jacqueline A Shipley; Ariane L Herrick; Andrea K Murray
Journal:  Arthritis Rheumatol       Date:  2018-04-23       Impact factor: 10.995
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.